The DOI matches its Crossref record.
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Abstract
Islet amyloid has been recognized as a pathological entity in type 2 diabetes since the turn of the century. It has as its unique component the islet beta-cell peptide islet amyloid polypeptide (IAPP), or amylin, which is cosecreted with insulin. In addition to this unique component, islet amyloid contains other proteins, such as apolipoprotein E and the heparan sulfate proteoglycan perlecan, which are typically observed in other forms of generalized and localized amyloid. Islet amyloid is observed at pathological examination in the vast majority of individuals with type 2 diabetes but is rarely observed in humans without disturbances of glucose metabolism. In contrast to IAPP from rodents, human IAPP has been shown to form amyloid fibrils in vitro. Because all human subjects produce and secrete the amyloidogenic form of IAPP, yet not all develop islet amyloid, some other factor(s) must be involved in islet amyloid formation. One hypothesis is that an alteration in beta-cell function resulting in a change in the production, processing, and/or secretion of IAPP is critical to the initial formation of islet amyloid fibrils in human diabetes. This nidus of amyloid fibrils then allows the progressive accumulation of IAPP-containing fibrils and the eventual replacement of beta-cell mass by amyloid and contributes to the development of hyperglycemia. One factor that may be involved in producing the changes in the beta-cell that result in the initiation of amyloid formation is the consumption of increased dietary fat. Dietary fat is known to alter islet beta-cell peptide production, processing, and secretion, and studies in transgenic mice expressing human IAPP support the operation of this mechanism. Further investigation using this and other models should provide insight into the mechanism(s) involved in islet amyloidogenesis and allow the development of therapeutic agents that inhibit or reverse amyloid fibril formation, with the goal being to preserve beta-cell function and improve glucose control in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One factor that we and others have been examining is the deposition of amyloid, which is found in the islets of up to 90% of patients with Type 2 diabetes [128, 129].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [129]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 201–300 of 488
Pappalardo, G., Milardi, D., Magrì, A., Attanasio, F., Impellizzeri, G., Rosa, C. L., Grasso, D., & Rizzarelli, E. (2007) · Chemistry · doi:10.1002/chem.200700576 · Cited by 37
Hull, R. L., Johnson, P. Y., Braun, K. R., Day, A. J., & Wight, T. N. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412457048 · Cited by 39
Membrane Permeation Induced by Aggregates of Human Islet Amyloid Polypeptides
Poojari, C., Xiao, D., Batista, V. S., & Strodel, B. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.09.045 · Cited by 39
Law, E., Lu, S., Kieffer, T. J., Warnock, G. L., Ao, Z., Woo, M., & Marzban, L. (2010) · Diabetologia · doi:10.1007/s00125-010-1717-9 · Cited by 39
Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity
Pilkington, E. H., Xing, Y., Wang, B., Käkinen, A., Wang, M., Davis, T. P., Ding, F., & Ke, P. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-02597-0 · Cited by 39
IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes
Blencowe, M., Furterer, A., Wang, Q., Gao, F., Rosenberger, M., Pei, L., Nomoto, H., Mawla, A. M., Huising, M. O., Coppola, G., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05569-2 · Cited by 40
β‐Cell mass plasticity in type 2 diabetes
Prato, S. D., Wishner, W. J., Gromada, J., & Schluchter, B. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00360.x · Cited by 39
Mammalian amyloidogenic proteins promote prion nucleation in yeast
Chandramowlishwaran, P., Sun, M., Casey, K. L., Romanyuk, A. V., Grizel, A. V., Sopova, J. V., Rubel, A. A., Nussbaum-Krammer, C. I., Vorberg, I. M., & Chernoff, Y. O. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809004 · Cited by 39
Pancreatic islet dysfunction in type 2 diabetes mellitus
Hu, F., Qiu, X., & Bu, S. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1510967 · Cited by 36
Determinants and dynamics of pancreatic islet architecture
Adams, M. T., & Blum, B. (2022) · Islets · doi:10.1080/19382014.2022.2030649 · Cited by 44
Höppener, J. W. M., Jacobs, H. M., Wierup, N., Sotthewes, G., Sprong, M., de Vos, P., Berger, R., Sundler, F., & Åhrén, B. (2008) · Journal of Diabetes Research · doi:10.1155/2008/697035 · Cited by 38
Mechanisms for Hyperglycemia in the Metabolic Syndrome: The Key Role of β‐Cell Dysfunction
Porte, D. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07786.x · Cited by 38
Human Amylin: From Pathology to Physiology and Pharmacology
Ling, W., Huang, Y., Qiao, Y.-C., Zhang, X., & Zhao, H. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190328111833 · Cited by 37
Effect of Lipid Type on the Binding of Lipid Vesicles to Islet Amyloid Polypeptide Amyloid Fibrils
Sasahara, K., Hall, D. R., & Hamada, D. (2010) · Biochemistry · doi:10.1021/bi9019252 · Cited by 37
Gregoire, C. J., Marco, S., Thimonier, J., Duplan, L., Laurine, E., Chauvin, J., Michel, B. F., Peyrot, V., & Verdier, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3313 · Cited by 37
Ghanaat‐Pour, H., Huang, Z., Lehtihet, M., & Sjöholm, Å. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0002 · Cited by 39
Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?
Höppener, J. W. M., Nieuwenhuis, M. G., Feltkamp‐Vroom, T. M., Åhrén, B., & Lips, C. J. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00266-6 · Cited by 36
Vibrational Sum-Frequency Scattering for Detailed Studies of Collagen Fibers in Aqueous Environments
Johansson, P. K., & Koelsch, P. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508190d · Cited by 35
Mulder, H., Gebré‐Medhin, S., Betsholtz, C., Sundler, F., & Åhrén, B. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.4.e684 · Cited by 35
Ma, Z., & Westermark, G. (2002) · Molecular Medicine · doi:10.1007/bf03402092 · Cited by 35
Amylin-Induced Cytotoxicity Is Associated with Activation of Caspase-3 and MAP Kinases
Rumora, L., Hadžija, M. P., Bariic, K., Maysinger, D., & Grubiic, T. Z. (2002) · Biological Chemistry · doi:10.1515/bc.2002.196 · Cited by 35
Oophorectomy promotes islet amyloid formation in a transgenic mouse model of Type II diabetes
Kahn, S. E., Andrikopoulos, S., Verchere, C. B., Wang, F., Hull, R. L., & Vidal, J. (2000) · Diabetologia · doi:10.1007/s001250051527 · Cited by 35
Self-citationVázquez, R., Riveiro, M. E., Berenguer‐Daizé, C., O’Kane, A. A., Gormley, J. A., Touzelet, O., Rezaï, K., Békradda, M., & Ouafik, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.589218 · Cited by 38
Schuh, A. F. S., Rieder, C. R. D. M., Rizzi, L., Chaves, M. L. F., & Roriz‐Cruz, M. (2011) · ISRN Neurology · doi:10.5402/2011/306905 · Cited by 34
Adeno-associated virus vector mediated gene transfer to pancreatic beta cells
Prasad, K.-M. R., Yang, Z., Bleich, D., & Nadler, J. L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301279 · Cited by 34
Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson’s disease
Meng, L., Li, Y., Liu, C., Zhang, G., Chen, J., Xiong, M., Pan, L., Zhang, X., Chen, G., Xiong, J., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102462 · Cited by 34
Amyloid Formation in Human Islets Is Enhanced by Heparin and Inhibited by Heparinase
Potter, K. J., Werner, I., Denroche, H. C., Montané, J., Plesner, A., Chen, Y., Lei, D. S., Soukhatcheva, G., Warnock, G. L., Oberholzer, J., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13134 · Cited by 34
Self-citationNedumpully-Govindan, P., Yang, Y., Andorfer, R. E., Cao, W., & Ding, F. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00891 · Cited by 33
Saini, R. K., Goyal, D., & Goyal, B. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00416 · Cited by 33
Altered Membrane Mechanics Provides a Receptor‐Independent Pathway for Serotonin Action
Dey, S., Surendran, D., Engberg, O., Gupta, A., Fanibunda, S. E., Das, A., Maity, B. K., Dey, A., Vishvakarma, V., Kallianpur, M., et al. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202100328 · Cited by 35
Complement activation by islet amyloid polypeptide (IAPP) and α-synuclein 112
Klegeris, A., & McGeer, P. L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.055 · Cited by 35
Amylin in the Periphery II: An Updated Mini-Review
Wookey, P. J., Lutz, T. A., & Andrikopoulos, S. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.263 · Cited by 31
Self-citationFiber-Dependent and -Independent Toxicity of Islet Amyloid Polypeptide
Schlamadinger, D. E., & Miranker, A. D. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.09.047 · Cited by 32
Gillies, N. A., Pendharkar, S. A., Singh, R. G., Windsor, J. A., Bhatia, M., & Petrov, M. S. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1308382 · Cited by 32
Single-Molecular Heteroamyloidosis of Human Islet Amyloid Polypeptide
Käkinen, A., Xing, Y., Arachchi, N. D. H., Javed, I., Feng, L., Faridi, A., Douek, A. M., Sun, Y., Kaslin, J., Davis, T. P., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02771 · Cited by 32
Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective
Hassan, S., White, K., & Terry, C. (2022) · Bioscience Reports · doi:10.1042/bsr20211297 · Cited by 36
Xu, W., Jiang, P., & Mu, Y. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8106827 · Cited by 32
Gur, E., Biran, D., Shechter, N., Genevaux, P., Georgopoulos, C. P., & Ron, E. Z. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.21.7236-7242.2004 · Cited by 32
Diabetes mellitus and the key role of endoplasmic reticulum stress in pancreatic β cells
Lytrivi, M., Tong, Y. A., Virgilio, E., Yi, X., & Cnop, M. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01129-5 · Cited by 36
Altering Peptide Fibrillization by Polymer Conjugation
Dehn, S., Castelletto, V., Hamley, I. W., & Perrier, S. (2012) · Biomacromolecules · doi:10.1021/bm3007117 · Cited by 30
Zheng, X., Ren, W., Zhang, S., Liu, J., Li, S., Li, J., Yang, P., He, J., Su, S., & Li, P. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0201-9 · Cited by 30
Vidal, J., Verchere, C. B., Andrikopoulos, S., Wang, F., Hull, R. L., Cnop, M., Olin, K., LeBoeuf, R. C., O’Brien, K. D., Chait, A., et al. (2003) · Diabetologia · doi:10.1007/s00125-002-0984-5 · Cited by 30
Self-citationWang, H., Cao, P., & Raleigh, D. P. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.003 · Cited by 29
Tang, J., Pei, Y., & Zhou, G. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.04.013 · Cited by 28
Findings in pancreatic MRI associated with pancreatic fibrosis and HbA1c values
Noda, Y., Goshima, S., Tanaka, K. Y., Osada, S., Tomita, H., Hara, A., Horikawa, Y., Takeda, J., Kajita, K., Watanabe, H., et al. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25019 · Cited by 28
Changes in Dynamic Insulin and Gastrointestinal Hormone Secretion in Obese Children
Roth, C. L., Bongiovanni, K. D., Gohlke, B. C., & Woelfle, J. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.204 · Cited by 28
Stepwise oligomerization of murine amylin and assembly of amyloid fibrils.
Palmieri, L., Melo-Ferreira, B., Braga, C., Fontes, G. N., Mattos, L., & Lima, L. M. T. R. (2013) · Biophysical Chemistry · doi:10.1016/j.bpc.2013.07.013 · Cited by 23
Bahramikia, S., & Yazdanparast, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.017 · Cited by 28
Alzheimer's disease and natural cognitive aging may represent adaptive metabolism reduction programs
Reser, J. E. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-13 · Cited by 28
Gene Therapy to Improve Pancreatic Islet Transplantation for Type 1 Diabetes Mellitus
Hughes, A., Jessup, C. F., Drogemuller, C., Mohanasundaram, D., Milner, C. R., Rojas, D., Russ, G. R., & Coates, P. T. H. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793360897 · Cited by 28
Li, X., Wan, M., Gao, L., & Fang, W. (2016) · Scientific Reports · doi:10.1038/srep21614 · Cited by 28
β‐cell deterioration – prospects for reversal or prevention
Finegood, D. T., & Topp, B. G. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00030.x · Cited by 28
Striegel, D. A., Hara, M., & Periwal, V. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004423 · Cited by 27
Translational Control of Glucose-Induced Islet Amyloid Polypeptide Production in Pancreatic Islets
Alarcón, C., Verchere, C. B., & Rhodes, C. J. (2012) · Endocrinology · doi:10.1210/en.2011-2019 · Cited by 27
Self-citationGasa, R., Gomis, R., Casamitjana, R., & Novials, A. (2001) · Pancreas · doi:10.1097/00006676-200104000-00013 · Cited by 27
Mulder, H., Gebré‐Medhin, S., Betsholtz, C., Sundler, F., & Åhrén, B. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f684 · Cited by 27
The gut sensor as regulator of body weight
Reinehr, T., & Roth, C. L. (2014) · Endocrine · doi:10.1007/s12020-014-0518-1 · Cited by 28
Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance
Ye, J.-M., Lim-Fraser, M., Cooney, G. J., Cooper, G. J. S., Iglesias, M. A., Watson, D. G., Choong, B., & Kraegen, E. W. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.4.e562 · Cited by 26
Milardi, D., Pappalardo, M., Pannuzzo, M., Grasso, D., & Rosa, C. L. (2008) · Chemical Physics Letters · doi:10.1016/j.cplett.2008.07.110 · Cited by 25
On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides
Tomasello, M. F., Sinopoli, A., & Pappalardo, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/918573 · Cited by 26
Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects
Tomita, T. (2012) · Islets · doi:10.4161/isl.20477 · Cited by 25
Animal Models of Alzheimer’s Disease
Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 25
Ultraeffective Inhibition of Amyloid Fibril Assembly by Nanobody–Gold Nanoparticle Conjugates
Zhao, L., Xin, Y., Li, Y., Yang, X., Luo, L., & Meng, F. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00797 · Cited by 24
Mathrani, A., Yip, W. C. Y., Sequeira, I. R., Barnett, D., Stevenson, O. G., Taylor, M. W., & Poppitt, S. D. (2023) · Nutrients · doi:10.3390/nu15153360 · Cited by 27
Wang, H., & Raleigh, D. P. (2014) · Biochemistry · doi:10.1021/bi4015488 · Cited by 24
Nucleobindin 1 Caps Human Islet Amyloid Polypeptide Protofibrils to Prevent Amyloid Fibril Formation
Gupta, R., Kapoor, N., Raleigh, D. P., & Sakmar, T. P. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.04.017 · Cited by 23
Andreasen, M., Nielsen, S. B., Runager, K., Christiansen, G., Nielsen, N. C., Enghild, J. J., & Otzen, D. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379552 · Cited by 24
Escherichia coli Proteome Microarrays Identified the Substrates of ClpYQ Protease
Tsai, C.-H., Ho, Y.-H., Sung, T., Wu, W.-F., & Chen, C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.065482 · Cited by 24
Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases
Andrikopoulos, N., Li, Y., Cecchetto, L., Nandakumar, A., Ros, T. D., Davis, T. P., Velonia, K., & Ke, P. C. (2020) · Nanoscale · doi:10.1039/d0nr04273k · Cited by 24
Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01
Attar, A., Rahimi, F., & Bitan, G. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0137-y · Cited by 24
Ueberberg, S., Nauck, M. A., Uhl, W. H., Montemurro, C., Tannapfel, A., Clark, A., & Meier, J. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa176 · Cited by 23
Amyloidosis of pancreatic islets in primary amyloidosis (AL type)
Tomita, T. (2005) · Pathology International · doi:10.1111/j.1440-1827.2005.01815.x · Cited by 23
Capcarová, M., Kalafová, A., Schwarzová, M., Schneidgenová, M., Prnová, M. Š., Švík, K., Slovák, L., Kisska, P., Kováčik, A., & Brindza, J. (2019) · Biologia · doi:10.2478/s11756-019-00337-5 · Cited by 22
Strong Electro‐Optic Effect and Spontaneous Domain Formation in Self‐Assembled Peptide Structures
Gilboa, B., Lafargue, C., Handelman, A., Shimon, L. J. W., Rosenman, G. I., Zyss, J., & Ellenbogen, T. (2017) · Advanced Science · doi:10.1002/advs.201700052 · Cited by 21
High-Oxygen-Content Carbon Dots as a High-Efficiency Inhibitor of Human Insulin Aggregation
Li, C., Liu, X., Li, S., Jiang, P., Jiang, F., & Liu, Y. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00583 · Cited by 22
Stefansson, S., Adams, D. L., & Tang, C. (2012) · BioTechniques · doi:10.2144/000113873 · Cited by 22
Bowen, R. F., Raikwar, N. S., Olson, L. K., & Deeg, M. A. (2001) · Metabolism · doi:10.1053/meta.2001.28087 · Cited by 22
Wang, L., Lei, L., Li, Y., Wang, L., & Li, F. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.020 · Cited by 22
Mulder, H., Mårtensson, H., Sundler, F., & Åhrén, B. (2000) · Metabolism · doi:10.1053/meta.2000.18511 · Cited by 22
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
Template Induced Conformational Change of Amyloid-β Monomer
Xi, W., Li, W., & Wang, W. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp300389g · Cited by 21
Amyloidogenicity of naturally occurring full‐length animal IAPP variants
Palato, L. M., Pilcher, S. M., Oakes, A., Lamba, A., Torres, J., Ledesma, L., Munoz, C., Njoo, E., Rinauro, D. J., Menefee, K., et al. (2019) · Journal of Peptide Science · doi:10.1002/psc.3199 · Cited by 21
Meng, F., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.028 · Cited by 21
Ilag, L. L., Tabaei, B. P., Herman, W. H., Zawacki, C. M., Dsouza, E. I., Bell, G. I., & Fajans, S. S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.961 · Cited by 21
Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome
Shenhar‐Tsarfaty, S., Bruck, T., Bennett, E. R., Bravman, T., Einor, B. A., Waiskopf, N., Rogowski, O., Bornstein, N. M., Berliner, S., & Soreq, H. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01165.x · Cited by 20
Identification of plant extracts that inhibit the formation of diabetes-linked IAPP amyloid
Fuentes, A. L., Hennessy, K., Pascual, J., Pepe, N., Wang, I., Santiago, A. L., Chaggan, C., Martinez, J., Rivera, E., Cota, P., et al. (2015) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2015.11.001 · Cited by 20
Membrane-mediated amyloid deposition of human islet amyloid polypeptide
Sasahara, K. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0351-x · Cited by 20
Molecular Dynamics Simulation Study on the Molecular Structures of the Amylin Fibril Models
Xu, W., Su, H., Zhang, J. Z. H., & Mu, Y. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp308708h · Cited by 19
The Role of Glycation on the Aggregation Properties of IAPP
Milordini, G., Zacco, E., Percival, M., Puglisi, R., Piaz, F. D., Temussi, P., & Pastore, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00104 · Cited by 20
The Rationale for Insulin Therapy in Alzheimer’s Disease
Ribarič, S. (2016) · Molecules · doi:10.3390/molecules21060689 · Cited by 20
Schiff base oxovanadium complexes resist the assembly behavior of human islet amyloid polypeptide
Xu, J., Gong, G., Huang, X., & Du, W. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.05.006 · Cited by 19
Diabetes: Magnitude and Mechanisms
Fowler, M. J. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.1.25 · Cited by 19
Oh, S. J., & Lee, M. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e276 · Cited by 18
Zhang, P., Zeng, L., Gao, W.-X., Li, H.-L., & Gao, Z.-H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.034 · Cited by 14
Bubak, A. N., Beseler, C. L., Como, C. N., Coughlan, C. M., Johnson, N. R., Hassell, J. E., Blackmon, A. M., Mescher, T., Schmid, D. S., Coleman, C., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa513 · Cited by 17
Zhou, X., Galparsoro, D. F., Madsen, A. Ø., Vetri, V., van de Weert, M., Nielsen, H. M., & Foderà, V. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.132 · Cited by 17
Inhibition of toxic IAPP amyloid by extracts of common fruits
Kao, P., Green, E., Pereira, C., Ekimura, S., Juarez, D., Whyte, T., Arhar, T., Malaspina, B., Nogaj, L. A., & Moffet, D. A. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.12.013 · Cited by 17
Abioye, R. O., Okagu, O. D., & Udenigwe, C. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041972 · Cited by 16
Garris, D. R., & Garris, B. L. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-1019-y · Cited by 16
Lin, J., Jiao, A., Lv, W., Zhang, C., Shi, Y., Yang, Z., Sun, N., Li, X., & Zhang, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00896 · Cited by 16
Metadata
- Authors
- Kahn, S. E., Andrikopoulos, S., & Verchere, C. B.
- Affiliations
- University of Washington (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1999-02-01
- Volume
- 48
- Issue
- 2
- Pages
- 241-253
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1992231742
- Cited by
- 488
- References
- 0
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 16 · 2021: 11 · 2020: 15 · 2019: 13 · 2018: 24 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 21 · 2013: 17 · 2012: 25
- FWCI
- 24.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050703, DK48152, DK50703, R01DK048152, DK-17047, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- islet amyloid, type 2 diabetes, amylin, beta-cell function, amyloid fibril formation, apolipoprotein E, perlecan, dietary fat, hyperglycemia, beta-cell mass loss, amyloidogenesis
- MeSH terms
- Amyloid, Amyloidosis, Animals, Diabetes Mellitus, Type 2, Dietary Fats, Humans, Islets of Langerhans, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review